Conference abstract · 7 Dec 2015
Conference abstractPublished 24 Dec 2015
Apoptotic-derived microparticles to endothelial-derived progenitor cells ratio as a novel biomarker in advanced heart failure patients
Zaporozhye Medical University, Ukraine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Acutely Decompensated Chronic Heart Failure (ADHF) is considered a life-threatening event. Despite contemporary treatment strategies of ADHF, frequent recurrent hospitalizations due to other cardiovascular reasons after discharge of patients from the hospital are occurred. The objective of the study was to examine prognostic value of circulating Endothelial-Derived Apoptotic Microparticles (EMPs) to endothelial origin Mononuclear Progenitor Cells (MPCs) ratio for post-discharged patients with clinical stabilization after ischemic ADHF. Methods: We have consecutively enrolled 136 patients (62 male) with CAD admitted with a primary diagnosis of ADHF. All the patients have given their written informed consent for participation in the study. At baseline, all enrolled patients were hemodynamically stable and they had NYHA III/IV classes of ischemic CHF. Observation period started at discharge from the hospital and was up to 3 years. Flow cytometry analysis for quantifying the number of EMPs and angiogenic MPCs was used. Results: Calculated EMPs to MPCs ratios in survived and died patient cohort were 8.4 (95% CI=7.6âÂ?Â?9.2) and 78.9 (95% CI=53.0âÂ?Â? 116.6), respectively (p=0.001). MPCs, EMPs, NYHA class, NT-proBNP and increased NT-proBNP >30% within 24-48 hours of admission period remained statistically significant for all-cause mortality, CHF-related death, and CHF-related rehospitalisation, whereas LVEF and hs-CRP for all variables did not. We found that the addition of EPMs to MPCs ratio to the ABC model (NT-pro- BNP, increased NT-pro-BNP>30%) improved the relative IDI by 19.6% for all-cause mortality, by 21.7% for CHF-related death, and by 19.5% for CHF-related rehospitalisation. Conclusion: We demonstrated that EMPs to MPCs ratio is considered more tremendous indicator of an imbalance between angiogenic and apoptotic responses with possible relation to cardiovascular outcomes in post-discharged patients with clinical stabilization after ischemic ADHF.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Mar 2017
Endothelial progenitor cells and apoptotic endothelial cell-derived microparticles as biomarker of heart failure phenotypes
Short communication · 31 Mar 2017
Endothelial Progenitor Cell Number to Apoptotic Endothelial Cell-Derived Micro Particles Ratio in Chronic Heart Failure Phenotypes
Research article · 2015
Impact of age on pattern of circulating endothelial-derived microparticles in heart failure patients
Research article · 31 Mar 2015
Inflammatory phenotype of circulating endothelial-derived microparticles in chronic heart failure patients with metabolic syndrome
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Alexander E Berezin”
